MedPath

Ayurvedic treatment for Visual Display Terminal Syndrome trial.

Phase 2
Conditions
Health Condition 1: H118- Other specified disorders of conjunctiva
Registration Number
CTRI/2023/07/054710
Lead Sponsor
Banaras Hindu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with minimum of daily exposure to VDTs for a duration of 3 hours.

Patients scoring more than or equal to 6 points in assessment of symptoms by reliable and valid questionnaire developed to measure Computer Vision Syndrome at workplace by Maria del Mar Segul etal and published in Journal of Clinical Epidemiology 2015.

Patients whose age range between 18 to 45 years.

Patients whose Tear Film Break-up Time is less than or equal to 6 seconds.

Patients whose Schirmerâ??s Test value is less than or equal to 10 seconds.

Patients with or without devitalized epithelial cells on conjunctiva to be assessed with Rose Bengal dye.

Exclusion Criteria

Patients not willing for registration.

Cases complicated with acute or chronic infective conjunctivitis, any specific eyelid disorders, corneal ulcers, dacryocystitis and lagopthalamos.

Patients suffering from any systemic or metabolic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in signs and symptoms as assessed by change in score using reliable and valid questionnaire developed to measure Computer Vision Syndrome at workplace by Maria del Mar Segul (etal) and published in Journal of Clinical Epidemiology (2015).Timepoint: Day 0, Day 15, Day 30, Day 60 (plus minus 2 days)
Secondary Outcome Measures
NameTimeMethod
Changes in Visual acuity, Tear film Break Up Time, Schirmers test, Rose Bengal staining.Timepoint: Day 0, Day 15, Day 30, Day 60 (plus minus 2 days)
© Copyright 2025. All Rights Reserved by MedPath